- Home
- MVIS vs RCKT Comparison
MVIS vs RCKT Comparison
Compare MVIS & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MVIS | RCKT |
|---|---|---|
| Founded | 1993 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 284.5M | 340.9M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | MVIS | RCKT |
|---|---|---|
| Price | $0.92 | $3.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 14 |
| Target Price | $2.50 | ★ $29.12 |
| AVG Volume (30 Days) | ★ 4.6M | 1.9M |
| Earning Date | 11-11-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,635,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $859.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.81 | $2.19 |
| 52 Week High | $1.95 | $13.30 |
Technical Indicators
Market Signals| Indicator | MVIS | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 51.66 | 56.14 |
| Support Level | $0.82 | $3.36 |
| Resistance Level | $0.92 | $3.64 |
| Average True Range (ATR) | 0.06 | 0.18 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 58.92 | 78.12 |
Price Performance
Historical ComparisonAbout MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.